TPP Follow-on GP I, Ltd. - Net Worth and Insider Trading

TPP Follow-on GP I, Ltd. Net Worth

The estimated net worth of TPP Follow-on GP I, Ltd. is at least $158 Million dollars as of 2025-05-30. TPP Follow-on GP I, Ltd. is the of Sipai Health Technology Co Ltd and owns about 40,852,974 shares of Sipai Health Technology Co Ltd (HKSE:00314) stock worth over $158 Million. Details can be seen in TPP Follow-on GP I, Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that TPP Follow-on GP I, Ltd. has not made any transactions after 2022-12-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of TPP Follow-on GP I, Ltd.

TPP Follow-on GP I, Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, TPP Follow-on GP I, Ltd. owns 1 companies in total, including Sipai Health Technology Co Ltd (HKSE:00314) .

Click here to see the complete history of TPP Follow-on GP I, Ltd.’s form 4 insider trades.

Insider Ownership Summary of TPP Follow-on GP I, Ltd.

Ticker	Company	Transaction Date	Type of Owner
HKSE:00314	Sipai Health Technology Co Ltd	2022-12-23

TPP Follow-on GP I, Ltd. Latest Holdings Summary

TPP Follow-on GP I, Ltd. currently owns a total of 1 stock. TPP Follow-on GP I, Ltd. owns 40,852,974 shares of Sipai Health Technology Co Ltd (HKSE:00314) as of December 23, 2022, with a value of $158 Million.

Latest Holdings of TPP Follow-on GP I, Ltd.

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:00314	Sipai Health Technology Co Ltd	2022-12-23	40,852,974	3.86	157,692,480

Holding Weightings of TPP Follow-on GP I, Ltd.

TPP Follow-on GP I, Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, TPP Follow-on GP I, Ltd. has made a total of 1 transactions in Sipai Health Technology Co Ltd (HKSE:00314) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Sipai Health Technology Co Ltd is the sale of 0 shares on December 23, 2022, which brought TPP Follow-on GP I, Ltd. around $0.

Insider Trading History of TPP Follow-on GP I, Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

TPP Follow-on GP I, Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

TPP Follow-on GP I, Ltd. Ownership Network

Ownership Network List of TPP Follow-on GP I, Ltd.

No Data

Ownership Network Relation of TPP Follow-on GP I, Ltd.

TPP Follow-on GP I, Ltd. Owned Company Details

What does Sipai Health Technology Co Ltd do?

Who are the key executives at Sipai Health Technology Co Ltd?

TPP Follow-on GP I, Ltd. is the of Sipai Health Technology Co Ltd. Other key executives at Sipai Health Technology Co Ltd include Impresa Management LLC , 2201 Interest of corporation controlled by you Eight Roads Holdings L.P. , and 2201 Interest of corporation controlled by you Eight Roads Management Limited .

Sipai Health Technology Co Ltd (HKSE:00314) Insider Trades Summary

Over the past 18 months, TPP Follow-on GP I, Ltd. made no insider transaction in Sipai Health Technology Co Ltd (HKSE:00314). Other recent insider transactions involving Sipai Health Technology Co Ltd (HKSE:00314) include a net sale of 9,000,000 shares made by Crow Lane Limited , a net sale of 9,000,000 shares made by FIL Limited , and a net sale of 9,000,000 shares made by Pandanus Partners L.P. .

In summary, during the past 3 months, insiders sold 0 shares of Sipai Health Technology Co Ltd (HKSE:00314) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 93,617,536 shares of Sipai Health Technology Co Ltd (HKSE:00314) were sold and 0 shares were bought by its insiders, resulting in a net sale of 93,617,536 shares.

Sipai Health Technology Co Ltd (HKSE:00314)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sipai Health Technology Co Ltd Insider Transactions

No Available Data

TPP Follow-on GP I, Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for TPP Follow-on GP I, Ltd.. Currently GuruFocus does not have mailing address information for TPP Follow-on GP I, Ltd..

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.